12-HETE
metabolite12-HETE is an eicosanoid mediator that activates platelets and amplifies oxidative stress during acute MI.
Pathway placement
Cascade stepPlatelet adhesion & activation
Confidencehigh
RationaleEicosanoid mediator; platelet activation marker; oxidative stress in acute MI.
Also acts inVascular inflammation
Druggability
Not assessed (no mapped human gene target).
Type I vs Type II discrimination
ScoresLow-confidence (proxy)
R — rupture / Type-I45
C — confounder / Type-II51
A — assay feasibility42
E — evidence strength21
T1DI (composite)4
Specificity differential (R−C)-5.2
Confounder panel (Type-II drivers)
No confounder evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum, plasma or urine
Collection tube
Serum separator (gold/red-top, SST) · Lithium heparin (green-top) · Sterile urine container
Method / principle
LC-MS/MS (targeted metabolomics) or enzymatic colorimetric where available
Reagent / substrate
Stable-isotope-labeled internal standard (MS); or enzyme-coupled Trinder reagent
Platform
LC-MS/MS; some automated chemistry
Turnaround · availability
Send-out / research · Specialized / research
Literature evidence(2)
- The potential effective components from Danlou tablet attenuates acute myocardial infarction by restoring ALOX12-mediated perturbed oxylipins.Journal of ethnopharmacology · 2025 · PMID 40086610 · doi
- Changes in platelet function independent of pharmacotherapy following coronary intervention in non-ST-elevation myocardial infarction patients.Atherosclerosis · 2015 · PMID 26431592 · doi